Our results showed that expression of constitutively active and standard treatment resistant p95ErbB2 in breast cancer cells induces macropinocytosis and increases the expression of cholesterol trafficking protein NPC1 and results in increased extracellular cholesterol uptake. This evidence concerns the gene NPC1 and breast carcinoma.